MC
Marks & Clerk
More
Marks & Clerk is one of the UK’s foremost firms of Patent and Trade Mark Attorneys. Our attorneys and solicitors are wired directly into the UK’s leading business and innovation economies. Alongside this we have offices in 9 international locations covering the EU, Canada and Asia, meaning we offer clients the best possible service locally, nationally and internationally.
Yesterday I had the pleasure of attending the Carbon-Loop Sustainable Manufacturing Launch Event, held in the magnificent surroundings of the Royal College of Physicians in Edinburgh.
United Kingdom
Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.
Yesterday I had the pleasure of attending the Carbon-Loop
Sustainable Manufacturing Launch Event, held in the magnificent
surroundings of the Royal College of Physicians in Edinburgh. The
venue felt fitting for a programme as ambitious as the Carbon-Loop
Sustainable Biomanufacturing Hub (C‑Loop). Edinburgh has long
been a centre of cutting‑edge medical research and is now
home to world‑leading work in industrial biotechnology.
C‑Loop itself is a £14 million collaboration
spanning six universities and a wide network of industrial
partners, all united around a single mission: advancing innovation
in sustainable manufacturing by bringing together chemistry,
biology and engineering.
As a chemist (who also loves a bit of biology!), one example
from researchers in the Wallace group particularly captured my
imagination: the synthesis of paracetamol from polyethylene
terephthalate (PET), a material used in plastic bottles.
Depolymerising PET provides the terephthalic acid monomer, which
can then be derivatised and—through auxotroph
rescue—converted into para‑aminobenzoic acid. This
intermediate was subsequently transformed into paracetamol using
genetically engineered E. coli.
It was a striking demonstration that “waste” is
often anything but. What we commonly refer to as waste is actually
a carbon‑rich feedstock—a resource that can be
transformed into high‑value products through imaginative
science and clever engineering. This idea of reframing waste as
opportunity ran through much of the day’s discussion and
highlighted just how much potential C‑Loop aims to
unlock.
The panel also explored the main challenges of bringing these
technologies to market. The experts discussed the need for
government support, policy change, and clarity on which policy
levers might be most effective, as well as the real difficulty of
securing the level of investment required to scale up these
solutions. Innovators in biotechnology routinely face the
well‑known challenge of navigating the “biotech valley
of death.”
From an investor perspective, emerging biotech innovations can
appear inherently more risky—biology is unpredictable,
performance at scale can shift dramatically, and the costs of
establishing a pilot plant can make the risk untenable. The
C‑Loop Manufacturing Hub aims to address some of these
barriers by establishing the UK’s first BioFactory, a
dedicated platform for waste analysis, sustainability evaluation
and scale‑up. I was also pleased to see the panel acknowledge
the importance of a strong intellectual property strategy. A robust
IP approach is not the whole answer, but patents can be a critical component in
de‑risking investment and helping early‑stage
technologies move toward commercial viability.
I left the launch event energised by what might emerge from
C‑Loop in the coming years. The convergence of disciplines,
the scale of collaboration and the shared commitment to reshaping
manufacturing into something genuinely sustainable all feel both
timely and essential.
A new sustainable manufacturing hub will use engineering biology
techniques to transform carbon-based waste usually destined for
landfill into next-generation materials including pharmaceuticals
and cosmetics.
edinburgh-innovations.ed.ac.uk/…
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.